Citigroup Inc Novavax Inc Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Novavax Inc stock. As of the latest transaction made, Citigroup Inc holds 859,870 shares of NVAX stock, worth $10 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

859,870

Previous 1,755,810 51.03%

Holding current value

$10 Million

Previous $8.39 Million 29.71%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$3.89 - $20.97 $3.49 Million - $18.8 Million	-895,940 Reduced 51.03%	859,870 $10.9 Million
Q1 2024 May 10, 2024	BUY	$3.76 - $6.02 $2.11 Million - $3.38 Million	562,053 Added 47.08%	1,755,810 $8.39 Million
Q4 2023 Feb 09, 2024	SELL	$4.8 - $7.67 $1.78 Million - $2.85 Million	-371,196 Reduced 23.72%	1,193,757 $5.73 Million
Q3 2023 Nov 09, 2023	BUY	$6.81 - $9.74 $7.5 Million - $10.7 Million	1,101,180 Added 237.44%	1,564,953 $11.3 Million
Q2 2023 Aug 10, 2023	SELL	$6.67 - $9.52 $8.26 Million - $11.8 Million	-1,239,048 Reduced 72.76%	463,773 $3.45 Million
Q1 2023 May 11, 2023	BUY	$5.76 - $12.48 $804,648 - $1.74 Million	139,696 Added 8.94%	1,702,821 $11.8 Million
Q4 2022 Feb 09, 2023	BUY	$8.86 - $25.04 $1.19 Million - $3.37 Million	134,767 Added 9.44%	1,563,125 $16.1 Million
Q3 2022 Nov 10, 2022	BUY	$18.2 - $76.12 $3.74 Million - $15.6 Million	205,555 Added 16.81%	1,428,358 $26 Million
Q2 2022 Aug 10, 2022	BUY	$36.28 - $75.29 $29.5 Million - $61.2 Million	812,996 Added 198.39%	1,222,803 $62.9 Million
Q1 2022 May 12, 2022	BUY	$69.73 - $142.9 $15.4 Million - $31.6 Million	221,317 Added 117.42%	409,807 $30.2 Million
Q4 2021 Feb 10, 2022	BUY	$134.56 - $217.97 $9.46 Million - $15.3 Million	70,276 Added 59.45%	188,490 $27 Million
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $21 Million - $32 Million	118,214 New	118,214 $24.5 Million

Others Institutions Holding NVAX

# of Institutions

284

Shares Held

83.2M

Call Options Held

5.43M

Put Options Held

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $910M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account